Peran Gender Dan Interval Puasa Pada Profil Lipid Tikus Wistar Dengan Diet Atherogenik
DOI:
https://doi.org/10.33474/jki.v7i2.8925Keywords:
Atherogenic diet, Time-restricted feeding, HDL, LDL, Triglyceride, Cholesterol.Abstract
 Introduction: Atherogenic diet can induced.hyperlipidemia leading to abnormal lipid profile. Time restricted feeding is proposed as treatment for hyperlipidemia. However, the effect of gender and which type of time-restricted feeding is the best to alter lipid profile is unknown.
Method: The study was conducted in female and male wistar rats which was devided into 5 groups, Negative Control (KN, n=8), Positive Control (KP, n=8), Daily restricted group (KRam, n=8), alternate restricted group (KDaud, n=8) and Monday-Thursday restricted group (KSeKa, n=8) respectively. Atherogenic diet were administrated for six weeks followed by 4 weeks of time-restricted feeding. At 15 weeks of age, all rats were humanely culled and serum samples were collected for analyses. Lipid profile were assesed using spectrophotometry and analysed using two way Anova followed by post hoc LSD and p < 0.05 is considered as statiscally significant.
Results: Gender and time restricted feeding affects serum total cholesterol and non-HDL cholesterol levels while gender influenced HDL and time restricted feeding influenced LDL levels. Both gender and time restricted feeding did not altered trigliseride level. Interestingly, no significant differences were found in lipid profile of KN vs KP in male or female group. Time restricted feeding had no significant effect in male but significant effect on female with higher, undesireable lipid profile.
Conclusion: Atherogenic diets did not lipid profile in male or female rats, but higher lipid profile were observed in female with atherogenic diet. Time restricted feeding has gender related effect cholesterol and non-HDL cholesterol level, but no gender effect on LDL. HDL is solely dependent on gender and not affected by atherogenic diet or time restricted feeding.
References
World Health Organization, Global
Nutrition Targets 2025. Childhood
Overweight. Policy Brief, W.H.
Organization, Editor. 2012, WHO/NMH/NHD/14.6. p. 1-8.
Balitbangkes, Riset Kesehatan Dasar (Riskesdas 2013), B.P.d.P.K.K.K.R. Indonesia, Editor. 2013: Jakarta.
Reilly, J.J., Obesity in childhood and adolescence: evidence based clinical and public health perspectives. Postgraduate
edical Journal, 2006. 82.(969): p. 429– 437.
Triliana, R., D.W. Soeatmadji, and H. Kalim, Pengaruh Terapi Suplementasi Fitosterol pada Profil Lemak Plasma, Kadar Apolipoprotein (Apo) B-48, dan Penghitungan Sel Busa Aorta Tikus Pascadiet Atherogenik. Journal of Experimental Life Science, 2012. 2(2): p. 70 - 81.
AlAlwan, I. and A. AlBanyan, Effects of Ramadan fasting on children with Type 1 diabetes. International Journal of Diabetes Mellitus, 2010. 2 p. 127–129.
Adlouni, A., et al., Beneficial effect on serum apo AI, apo B and Lp AI levels of Ramadan fasting. Clinica Chimica Acta, 1998. 271 p. 179–189.
Jensen, T.L., et al., Fasting of mice: a review. . Laboratory Animals, 2013. 47(4): p. 225–40.
Asarian, L. and N. Geary, Sex differences in the physiology of eating. Am J Physiol Regul Integr Comp Physiol, 2013. 305(11): p. R1215-67.
Barton,M.,Cholesteroland
atherosclerosis: modulation by
oestrogen. Curr Opin Lipidol, 2013.
(3): p. 214-20.
Bush, T.L. and E. Barrett-Connor, Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev, 1985. 7: p. 89-104.
Lopez, D. and M.P. McLean, Estrogen regulation of the scavenger receptor class B gene: Anti-atherogenic or steroidogenic, is there a priority? Mol Cell Endocrinol, 2006. 247(1-2): p. 22-33.
Masuda, D., et al., Fasting serum apolipoprotein B-48 can be a marker of
postprandial hyperlipidemia. J
Atheroscler Thromb, 2011. 18(12): p.
-70.
Browning, J.D. and J.D. Horton, Fasting reduces plasma proprotein convertase, subtilisin/kexin type 9 and cholesterol biosynthesis in humans. J Lipid Res, 2010. 51(11): p. 3359-63.
Downloads
Published
Issue
Section
License
Jurnal Kesehatan Islam : Islamic Health Journal dengan nomor registrasi ISSN 2303-002X (cetak) 2615-8345 (online) yang diterbitkan oleh Fakultas Kedokteran Universitas Islam Malang menerapkan ketentuan Hak Cipta dan Lisensi sebagai berikut:
Â
Hak cipta:
- Hak Cipta pada setiap naskah adalah milik penulis.
- Penulis mengakui bahwa Jurnal Kesehatan Islam : Islamic Health Journal berhak sebagai yang pertama kali mempublikasikan dengan lisensi Creative Commons Attributions-ShareAlike 4.0 International License.
- Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain dengan mengakui bahwa naskah telah terbit pertama kali pada Jurnal Kesehatan Islam : Islamic Health Journal.
Lisensi:
- Atribusi: Anda harus mencantumkan nama yang sesuai, mencantumkan tautan terhadap lisensi, dan menyatakan bahwa telah ada perubahan yang dilakukan. Anda dapat melakukan hal ini dengan cara yang sesuai, namun tidak mengisyaratkan bahwa pemberi lisensi mendukung Anda atau penggunaan Anda.
- Berbagi Serupa: Apabila Anda menggubah atau membuat turunan dari materi ini, Anda harus menyebarluaskan kontribusi Anda di bawah lisensi yang sama dengan materi asli.
- Tidak ada batasan tambahan: Anda tidak dapat menggunakan ketentuan hukum atau sarana kontrol teknologi yang secara hukum membatasi orang lain untuk melakukan hal-hal yang diizinkan lisensi ini.
Anda bebas untuk:
- Berbagi menyalin dan menyebarluaskan kembali materi ini dalam bentuk atau format apapun.
- Beradaptasi mengubah dan membuat turunan dari materi ini untuk kepentingan apapun, termasuk kepentingan komersial.
- Pemberi lisensi tidak dapat mencabut ketentuan di atas sepanjang Anda mematuhi ketentuan lisensi ini.